Sleep drug pipelines

Johnson & Johnson

JNJ-922

Primary insomnia

Orexin-2-antagonist

Filing/approval


Eisai

lemborexant

Insomnia

orexin receptor antagonist

Phase II


Eisai

E2006

Insomnia

Phase II